Company Executives

Management Team

From the 10-K annual report

Officer	Age	In this role	Joined	2022 pay	Source
Dean L. Julia Also a director Chief Executive Officer, President, Treasurer, Director, Co-Founder	58	Not stated	Not stated	$422,984

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 10-K annual report

Directors

serving now

Independent

Not stated

the proxy does not say

Average tenure

9.0 years

from year joined

CEO also chairs the board

Gene Salkind

Director	Age	On board	Independent	Committees	Other public boards	Pay
Gene Salkind Board chair	72	2019 7 years	Not stated	None stated	CURE Pharmaceutical Holding Corp.	Not stated
Dean L. Julia CEO	58	1998 28 years	Not stated	None stated	None stated	Paid as CEO
Anne S. Provost	62	2022 4 years	Not stated	None stated	None stated	Not stated
Nate Knight	76	2023 3 years	Not stated	None stated	None stated	Not stated
Byron Booker	53	2023 3 years	Not stated	None stated	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions not read yet

The latest proxy was filed Nov 30, 2023 and its related-party section is being read. Check back shortly.

Open the proxy

Comments